Menopause
News
Denosumab's Effect Greater in Selected Patients
News
Oral Calcitonin Scores for Osteoporosis in Phase III
News
Raloxifene Did Not Increase Lupus Activity in Study
Expert Commentary
VULVAR PAIN SYNDROMES A bounty of treatments—but not all of them are proven
Treatments for vulvodynia and vestibulodynia range from lifestyle adjustments and application of topical agents to tricyclic antidepressants and...
Clinical Review
Vulvar pain syndromes: Making the correct diagnosis
Many cases of generalized vulvodynia and localized vulvodynia (vestibulodynia) are mistakenly attributed to yeast infection, pudendal neuralgia,...
News
Asymptomatic Older Women Not on HRT May Have Polyps
Audio
The overall risks and benefits of hormone therapy
The new data on hormone therapy (HT) suggest that we still have much to learn about its benefits and risks. We also are reaching an understanding...
News
Women on Denosumab Maintain Bone Benefits After 5 Years
Clinical Review
UPDATE ON MENOPAUSE
Here is a roundup of the latest data on vitamin D requirements in women and how the route, timing, and duration of hormone therapy influence its...
Expert Commentary
Is hormone therapy still a valid option? 12 ObGyns address this question
Clinicians understand the risks and benefits of hormone therapy for menopausal women more precisely than ever—but has the pendulum swung too far...
From the Editor
Consider denosumab for postmenopausal osteoporosis
Easy to use and effective, this recently approved agent appears well suited to ObGyn office practice